SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Vasogen-- VAS on TSE -- Ignore unavailable to you. Want to Upgrade?


To: brb who wrote (181)8/8/1999 11:59:00 AM
From: jackil_54  Read Replies (1) | Respond to of 377
 
Is anyone watching this one?

Goldman bought about 200 000 shares in the last 2 days of trading. The price is up a little and rumours are at least one American company is very interested in Vasogen's technology. Don't have a clue when a deal may be signed but this thing could pop short term. If it doesn't then I would expect a double by the end of the year.

By the way, there are at least 4 analyst reports out there with BUY recommendations and price targets between 3.50 - 4.00 (if I remember correctly). I think what happened with this one is the company decided on doing some more R&D instead of commercialization. This strategy cost impatient shareholders to leave and cause the decline of the share price over the last 18 months.

However, the company presently has 4 different products (at vastly different stages of development) and a deal with Vasocare is expected this year at some time. I think this one is a good bet, any comments?